Activity of fibroblast growth factor receptor inhibitors TKI258, ponatinib and AZD4547 against TPR-FGFR1 fusion

Qiu, XH; Li, F; Cao, HQ; Shao, JJ; Mei, JG; Li, HQ; Zhai, YP

Zhai, YP (reprint author), Jinling Hosp, Dept Hematol, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.

MOLECULAR MEDICINE REPORTS, 2017; 15 (3): 1024

Abstract

8p11 myeloproliferative syndrome (EMS) is a rare disease characterized by the constitutive activation of fibroblast growth factor receptor 1 (FGFR1). ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索